Literature DB >> 31558996

Seroepidemiology and risk factors of hepatitis C virus infection in East Azerbaijan, Iran: a population-based Azar Cohort study.

Ali Asghar Pouri1, Morteza Ghojazadeh1, Behrouz Pourasghari2, Babak Baiaz2, Fatemeh Soghra Hamzavi2, Mohammad Hossein Somi1.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) is a blood-borne virus. It is a major global public health problem and can cause both acute and chronic hepatitis. The aim of this study was to report the epidemiological features of HCV infection and risk factors based on the data from Azar Cohort, East Azerbaijan province, Iran.
METHODS: The population of this study comprised the people in the age range of 35-70 years from Azar Cohort, East Azerbaijan province, Iran. The study was conducted between 2015 and 2016. Based on cluster sampling, 4, 949 people were selected and invited to complete the questionnaire and perform the tests. Blood samples collected in this study were analyzed to detect the presence of antibodies against HCV using enzyme immunoassay (ELISA) Kit. The positive samples were re-tested by qualitative HCV-RNA polymerase chain reaction. All data were analyzed using SPSS version 19.0 software.
RESULTS: The mean age of the participants was 49.15±9.02 years. Of these participants, 54.3% (n=2686) were females. Seven people (0.14%) were detected as HCV positive and the highest frequency was seen in the age range of 40-50 (0.16%). There was a statistical significant relationship between history of hospitalization (P=0.02) and history of abnormal urine (P=0.01) with the frequency of HCV infection.
CONCLUSION: The findings of this study indicated that the frequency of hepatitis C virus infection is 0.14% in the general population of Azar Cohort.

Entities:  

Keywords:  Azar Cohort; Hepatitis C; Iran; Seroepidemiology

Year:  2019        PMID: 31558996      PMCID: PMC6729152          DOI: 10.22088/cjim.10.3.326

Source DB:  PubMed          Journal:  Caspian J Intern Med        ISSN: 2008-6164


  26 in total

1.  The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.

Authors:  Joseph F Perz; Gregory L Armstrong; Leigh A Farrington; Yvan J F Hutin; Beth P Bell
Journal:  J Hepatol       Date:  2006-06-23       Impact factor: 25.083

2.  Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran.

Authors:  Amir Houshang Mohammad Alizadeh; Seyed Moayed Alavian; Khalil Jafari; Nastaran Yazdi
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

3.  Seroprevalence of hepatitis C virus: the first population-based study from Iran.

Authors:  Shahin Merat; Houri Rezvan; Mehdi Nouraie; Elham Jafari; Hassan Abolghasemi; Amir Reza Radmard; Hanieh Zaer-rezaii; Sedigheh Amini-Kafiabad; Mahtab Maghsudlu; Akram Pourshams; Reza Malekzadeh; Saeed Esmaili
Journal:  Int J Infect Dis       Date:  2010-04-02       Impact factor: 3.623

Review 4.  Epidemiology of hepatitis B and C viruses: a global overview.

Authors:  Helen S Te; Donald M Jensen
Journal:  Clin Liver Dis       Date:  2010-02       Impact factor: 6.126

5.  Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan.

Authors:  M F Khattak; N Salamat; F A Bhatti; T Z Qureshi
Journal:  J Pak Med Assoc       Date:  2002-09       Impact factor: 0.781

Review 6.  Transfusion-transmitted infections among multitransfused patients in Iran: a review.

Authors:  H Rezvan; H Abolghassemi; S Amini Kafiabad
Journal:  Transfus Med       Date:  2007-12       Impact factor: 2.019

7.  Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.

Authors:  Emma Ruth Miller; Peng Bi; Philip Ryan
Journal:  Int J Infect Dis       Date:  2008-09-13       Impact factor: 3.623

8.  Clinical significance of activity of ALT enzyme in patients with hepatitis C virus.

Authors:  Onder Akkaya; Murat Kiyici; Yusuf Yilmaz; Engin Ulukaya; Omer Yerci
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

9.  HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan.

Authors:  Catherine S Todd; Abdullah M S Abed; Steffanie A Strathdee; Paul T Scott; Boulos A Botros; Naqibullah Safi; Kenneth C Earhart
Journal:  Emerg Infect Dis       Date:  2007-09       Impact factor: 6.883

10.  Population-based surveillance for hepatitis C virus, United States, 2006-2007.

Authors:  R Monina Klevens; Jeremy Miller; Candace Vonderwahl; Suzanne Speers; Karen Alelis; Kristin Sweet; Elena Rocchio; Tasha Poissant; Tara M Vogt; Kathleen Gallagher
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.